🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an observational, longitudinal, prospective study for sample collec...
Status
Active Not Recruiting
Location
Institute of Human Virology, University of Maryland School of Medicine
Start Date
2014-12
Trial ID
NCT02995252
A total of 22 subjects will be included in the study. The subjects who were...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06557447
Study design Observational, single centre, prospective cohort study Planned...
Status
Completed
Location
Dr Wajid Khan
Start Date
2020-03-24
Trial ID
NCT04303455
Treatments Being Tested
Despite advances in medications, allergic diseases, including allergic asth...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2013-01
Trial ID
NCT01711593
Treatments Being Tested
This is an ancillary laboratory study to collect and bank blood and tissue ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07550049
Treatments Being Tested
This study investigated the effect of maternal holding-cuddling (MHC) and p...
Status
Completed
Location
Istanbul Medeniyet University
Start Date
2016-02-04
Trial ID
NCT06111534
Treatments Being Tested
Chronic inflammation in polycystic ovary syndrome (PCOS) may be the result ...
Status
Completed
Location
Jagiellonian University Medical College
Start Date
2024-01-15
Trial ID
NCT06300593
Treatments Being Tested
Although there are numerous studies that have demonstrated the impact of sy...
Status
Unknown
Location
Cardio Med Medical Center
Start Date
2022-08-05
Trial ID
NCT05488249
Treatments Being Tested
This phase III trial compares the effect of sentinel lymph node mapping to ...
Status
Recruiting
Location
George Washington University Medical Center
Start Date
2022-12-07
Trial ID
NCT05646316
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested